Anti-KAZALD1 antibodies are used in the immunodetection of the protein Kazal type serine peptidase inhibitor domain 1. In humans, the canonical protein has a reported length of 304 amino acid residues and a mass of 32.9 kDa. Its subcellular localization is in the extracellular matrix and is secreted. Up to 2 different isoforms have been reported for this protein. KAZALD1 is reported to be involved in proliferation of osteoblasts during bone formation and bone regeneration. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include IGFBP-related protein 10, bone- and odontoblast-expressed gene 1, novel kazal-type serine protease inhibitor domain and immunoglobulin domain containing protein, and kazal-type serine protease inhibitor domain-containing protein 1. KAZALD1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. These KAZALD1 antibodies are widely used in Western Blot experiments, among other applications.